Trends of blood pressure control in the U.S. during the COVID-19 pandemic - PubMed (original) (raw)
Trends of blood pressure control in the U.S. during the COVID-19 pandemic
Nishant P Shah et al. Am Heart J. 2022 May.
Abstract
Importance: COVID-19 altered lifestyles and disrupted routine health care. Whether blood pressure (BP) control worsened during COVID-19 is unknown.
Objective: To understand whether home BP control worsened during COVID-19 across the United States (US) .
Design, setting, and participants: A population-based analysis of home BP data from 72,706 participants enrolled in a digital health hypertension control program. Data was compared before (January 2019 to March 2020) and during (April 2020 to August 2020) COVID-19.
Main outcomes and measures: Monthly mean home BP readings, systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) were quantified before and during the pandemic. Multivariable adjustments were made for age, sex, race, region, and months enrolled. Home BP readings were also classified based on monthly averages and highest home BP readings into risk groups: Stage 2 HTN: BP> = 135 or DBP> = 85; Uncontrolled HTN: SBP> = 145 or DBP> = 95; or Severely uncontrolled HTN: SBP> = 160 or DBP> = 100).
Results: Overall, 72,706 participants were enrolled in a digital health hypertension program between 1/1/2019 and 8/31/2020. Compared with participants pre-COVID-19 (n = 33,440), those during COVID-19 (n = 39,266) were of similar age (mean 53.0 ± 10.7 years vs 53.3 ± 10.8 years); sex (46% vs 50.6% female) and race (29.1% vs 34.2% non-white). Relative to pre-Covid (Apr-Aug 2019) the mean monthly number of home BP readings rose during COVID-19 (Apr-Aug, 2020), from 7.3 to 9.3 per month (P < .001). During COVID-19, participants had higher monthly adjusted mean SBP (131.6 mmHg vs. 127.5 mmHg, P < .001); DBP (80.2 mmHg vs. 79.2 mmHg, P < .001); and MAP (97.4 mmHg vs. 95.3 mmHg; P < .001). Relative to the pre-pandemic period, during COVID-19 the proportion of participants with a mean monthly BP classified as uncontrolled or severely uncontrolled hypertension also rose, 15% vs 19% and 4% vs 5%, respectively CONCLUSIONS AND RELEVANCE: Based on home BP readings, mean monthly BP rose modestly after COVID-19, despite increased utilization of home monitoring. Further studies are needed to examine the longitudinal effects of the pandemic on cardiovascular disease risk factors, the impact of these on long-term population health.
Copyright © 2021. Published by Elsevier Inc.
Figures
Figure 1
Distribution of mean number of BP readings in 2019 and 2020 by month. The blue circles represent 2019; red plus represented Jan-Mar 2020; and green x represents the pandemic period of Apr-Aug 2020..
Figure 2
Distribution of monthly mean systolic blood pressure (A), diastolic blood pressure (B), and mean arterial blood pressure (C) readings in 2019 and 2020 in adjusted models. The blue circles represent 2019; red plus represented Jan-Mar 2020; and green x represents the pandemic period of Apr-Aug 2020. Adjustments were made for age, sex, race, region, and months in program. BP is measured in mmHg.
Figure 3
Mean differences between 2020 and 2019 by month for SBP and DBP. The average difference between 2019 and 2020 are displayed for systolic blood pressure and diastolic blood pressue.
Figure 4
Distribution of the adjusted proportion of participants with Stage 2 or higher (>=135 or DBP>= 85 o), uncontrolled BP (>=145 or DBP>= 95) and severely uncontrolled (>=160 or DBP>=100) categories in 2019 and 2020 classified by either a) monthly mean BP or b) peak blood pressure. The blue circles represent 2019; red plus represented Jan-Mar 2020; and green x represents the COVID-19 period of Apr-Aug 2020. Adjustments were made for age, sex, race, region, and months in program.
Similar articles
- Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study.
Obara T, Ohkubo T, Funahashi J, Kikuya M, Asayama K, Metoki H, Oikawa T, Hashimoto J, Totsune K, Imai Y. Obara T, et al. J Hypertens. 2005 Sep;23(9):1653-60. doi: 10.1097/01.hjh.0000178334.33352.56. J Hypertens. 2005. PMID: 16093909 - Heterogeneity of the Effect of Telemedicine Hypertension Management Approach on Blood Pressure: A Systematic Review and Meta-analysis of US-based Clinical Trials.
Acharya S, Neupane G, Seals A, Madhav KC, Giustini D, Sharma S, Taylor YJ, Palakshappa D, Williamson JD, Moore JB, Bosworth HB, Pokharel Y. Acharya S, et al. medRxiv [Preprint]. 2023 Sep 15:2023.09.14.23295587. doi: 10.1101/2023.09.14.23295587. medRxiv. 2023. PMID: 37745417 Free PMC article. Preprint. - Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial.
Margolis KL, Asche SE, Dehmer SP, Bergdall AR, Green BB, Sperl-Hillen JM, Nyboer RA, Pawloski PA, Maciosek MV, Trower NK, O'Connor PJ. Margolis KL, et al. JAMA Netw Open. 2018 Sep 7;1(5):e181617. doi: 10.1001/jamanetworkopen.2018.1617. JAMA Netw Open. 2018. PMID: 30646139 Free PMC article. Clinical Trial. - Blood pressure targets for hypertension in people with diabetes mellitus.
Arguedas JA, Leiva V, Wright JM. Arguedas JA, et al. Cochrane Database Syst Rev. 2013 Oct 30;2013(10):CD008277. doi: 10.1002/14651858.CD008277.pub2. Cochrane Database Syst Rev. 2013. PMID: 24170669 Free PMC article. Review. - Screening for Hypertension in Children and Adolescents: Systematic Review for the U.S. Preventive Services Task Force [Internet].
Gartlehner G, Vander Schaaf EB, Orr C, Kennedy SM, Clark R, Viswanathan M. Gartlehner G, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Nov. Report No.: 20-05261-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Nov. Report No.: 20-05261-EF-1. PMID: 33284560 Free Books & Documents. Review.
Cited by
- Changes in blood pressure measurement prevalence among United States adults with hypertension before and during the COVID-19 pandemic.
Otchere B, Vaughan AS, Richardson L, Wall HK, Coronado F. Otchere B, et al. Prev Med Rep. 2024 Aug 31;46:102878. doi: 10.1016/j.pmedr.2024.102878. eCollection 2024 Oct. Prev Med Rep. 2024. PMID: 39290259 Free PMC article. - The New Emerging Treatment Choice for Major Depressive Disorders: Digital Therapeutics.
Cho CH, Lee HJ, Kim YK. Cho CH, et al. Adv Exp Med Biol. 2024;1456:307-331. doi: 10.1007/978-981-97-4402-2_16. Adv Exp Med Biol. 2024. PMID: 39261436 Review. - National and Regional Trends in the Prevalence of Hypertension in South Korea Amid the Pandemic, 2009-2022: Nationwide Study of Over 3 Million Individuals.
Lee H, Kim M, Woo S, Park J, Kim HJ, Kwon R, Koyanagi A, Smith L, Kim MS, López Sánchez GF, Dragioti E, Lee J, Lee H, Rahmati M, Rhee SY, Lee JH, Woo HG, Yon DK. Lee H, et al. JMIR Public Health Surveill. 2024 Jul 30;10:e51891. doi: 10.2196/51891. JMIR Public Health Surveill. 2024. PMID: 39078683 Free PMC article. - Increased Resting and Peak Exercise Systolic Blood Pressure in Children Throughout the COVID-19 Pandemic.
Fernie JC, Pettit KA, Schaffer M, M Rausch C. Fernie JC, et al. Pediatr Cardiol. 2024 Feb 16. doi: 10.1007/s00246-024-03410-2. Online ahead of print. Pediatr Cardiol. 2024. PMID: 38366301 - Elevated Arterial Blood Pressure as a Delayed Complication Following COVID-19-A Narrative Review.
Bielecka E, Sielatycki P, Pietraszko P, Zapora-Kurel A, Zbroch E. Bielecka E, et al. Int J Mol Sci. 2024 Feb 2;25(3):1837. doi: 10.3390/ijms25031837. Int J Mol Sci. 2024. PMID: 38339115 Free PMC article. Review.
References
- Worldometer COVID-19 Tracker. 2021. https://www.worldometers.info/coronavirus/.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous